Stem Cell Transplant (SCT) for Dyskeratosis Congenita or SAA

NCT00455312 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Dyskeratosis Congenita
Aplastic Anemia

Interventions

DRUG: Campath 1H
DRUG: Cyclophosphamide
DRUG: Fludarabine
PROCEDURE: Total Body Irradiation
PROCEDURE: Stem Cell Transplantation
DRUG: antithymocyte globulin
DRUG: Methylprednisolone

Sponsor

Masonic Cancer Center, University of Minnesota